VistaGen Therapeutics, Inc.
VTGN
$3.22
$0.1555.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 63.18M | 80.48M | 88.56M | 97.58M | 108.36M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.54M | 1.59M | 1.38M | 2.37M | 2.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 66.72M | 82.08M | 89.94M | 99.95M | 110.84M |
|
|
|||||
| Total Current Assets | 66.72M | 82.08M | 89.94M | 99.95M | 110.84M |
| Net Property, Plant & Equipment | 1.74M | 1.81M | 1.89M | 2.05M | 2.19M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 472.00K | 454.00K | 477.00K | 498.00K | 518.00K |
| Total Assets | 68.92M | 84.34M | 92.31M | 102.50M | 113.55M |
|
|
|||||
| Total Accounts Payable | 486.00K | 653.00K | 1.04M | 715.00K | 1.21M |
| Total Accrued Expenses | 6.58M | 8.81M | 5.47M | 3.82M | 2.16M |
| Short-term Debt | 933.00K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 640.00K | 561.00K | 603.00K | 525.00K | 567.00K |
| Total Finance Division Other Current Liabilities | 2.51M | 2.59M | 2.51M | 2.47M | 2.30M |
| Total Other Current Liabilities | 2.51M | 2.59M | 2.51M | 2.47M | 2.30M |
| Total Current Liabilities | 11.16M | 12.61M | 9.62M | 7.52M | 6.24M |
|
|
|||||
| Total Current Liabilities | 11.16M | 12.61M | 9.62M | 7.52M | 6.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 933.00K | -- | -- | -- | -- |
| Capital Leases | 783.00K | 948.00K | 1.11M | 1.27M | 1.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 221.00K | 391.00K | 454.00K | 730.00K | 1.09M |
| Total Liabilities | 12.16M | 13.95M | 11.19M | 9.52M | 8.75M |
|
|
|||||
| Common Stock & APIC | 483.46M | 481.99M | 479.08M | 476.83M | 475.72M |
| Retained Earnings | -422.73M | -407.63M | -394.00M | -379.91M | -366.95M |
| Treasury Stock & Other | -3.97M | -3.96M | -3.96M | -3.95M | -3.97M |
| Total Common Equity | 56.77M | 70.39M | 81.12M | 92.97M | 104.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 56.77M | 70.39M | 81.12M | 92.97M | 104.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 56.77M | 70.39M | 81.12M | 92.97M | 104.80M |
|
|
|||||